Modelpedia
Work in progress
About
Findings
Models
Concepts
Methods
Datasets
Sources
Light
Dark
Therapeutic Antibody Profiler
anchor
Findings
IC-311
On siltuximab GRAVY reduction, Lambo-2 achieves the best concept shift while ESM2 produces the most naturalness-disrupted designs
[eval]